BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17559864)

  • 1. Maturation of mucosal immune responses and influence of maternal antibodies.
    Jónsdóttir I
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S20-6. PubMed ID: 17559864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responsiveness in the neonatal period.
    Morein B; Blomqvist G; Hu K
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S27-31. PubMed ID: 17548093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune system development in the dog and cat.
    Day MJ
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S10-5. PubMed ID: 17560591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of secretory immunity and memory at mucosal surfaces.
    Brandtzaeg P
    Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of vaccine responses in early life: selected examples.
    Siegrist CA
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S4-9. PubMed ID: 17559867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
    van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
    Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
    Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
    Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo.
    Zhang L; Zhang M; Li J; Cao T; Tian X; Zhou F
    Res Vet Sci; 2008 Dec; 85(3):495-502. PubMed ID: 18359498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies.
    Vidor E
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S42-5. PubMed ID: 17555761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucosal immunity and vaccine development].
    Anjuère F; Czerkinsky C
    Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
    Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
    Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
    Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
    Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
    Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
    Kayamuro H; Abe Y; Yoshioka Y; Katayama K; Nomura T; Yoshida T; Yamashita K; Yoshikawa T; Kawai Y; Mayumi T; Hiroi T; Itoh N; Nagano K; Kamada H; Tsunoda S; Tsutsumi Y
    Biomaterials; 2009 Oct; 30(29):5869-76. PubMed ID: 19646748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of environment on development of the mucosal immune system.
    Bailey M; Haverson K; Inman C; Harris C; Jones P; Corfield G; Miller B; Stokes C
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):189-98. PubMed ID: 16102842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host defenses: development and maternal contributions.
    Goldman AS; Ham Pong AJ; Goldblum RM
    Adv Pediatr; 1985; 32():71-100. PubMed ID: 3909786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.